Skip to content
DataLookout
Menu

NCT06762522

Exploring Feasibility, Acceptability and Impact of Using Neurofeedback with Persons with Mild Cognitive Impairment

StatusUnknown
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine updates

Endpoints

Primary

Feasibility Measure 1: Study participation rates
Timeframe: Data will be collected throughout the study enrolment period of three months
Feasibility Measure 2: Survey response rates
Timeframe: Data will be collected throughout the study enrolment and delivery period of six months.
Feasibility Measure 3: Study withdrawal rates
Timeframe: Data will be collected throughout the study enrolment and delivery period of six months.
Creyos Health Cognitive Assessment: Objective measure of cognition
Timeframe: Measurement will occur at three time points: (T0) at week 0, immediately before the first neurofeedback session, (T1) at week5, after the last neurofeedback session, and (T2) 5 weeks following the last neurofeedback session.
Feasibility Measure 4: Feasibility of Intervention Measure (FIM)
Timeframe: The FIM will be completed as part of the follow-up survey at T2, 5 weeks following the last neurofeedback session.
Feasibility Measure 5: Acceptability of Intervention Measure (AIM)
Timeframe: The AIM will be completed as part of the follow-up survey at T2, 5 weeks following the last neurofeedback session.
Feasibility Measure 6: Intervention Appropriateness Measure (IAM)
Timeframe: The IAM will be completed as part of the follow-up survey at T2, 5 weeks following the last neurofeedback session. Data will be collected throughout the study period of six months

Secondary (3)

Beck Anxiety Inventory: Anxiety
Beck Depression Inventory: Depression
Short-Form Pittsburgh Sleep Quality Index: Sleep quality

Arms and interventions

Nonlinear dynamical neurofeedback (NLD)Experimental

The NLD study intervention will consist of 10 sessions of NeurOptimal neurofeedback delivered twice a week over a 5-week period. The intervention will be delivered by a certified NeurOptimal trainer. The average session length is 45 minutes including setup. Additional time of 15-20 minutes will be required prior to sessions when the surveys are completed.

Low energy neurofeedback system (LENS)Experimental

The LENS study intervention will consist of 5 sessions of LENS neurofeedback delivered by a certified LENS trainer once a week over a 5-week period. The average session length is 15 minutes including setup. Additional time of 15-20 minutes will be required prior to sessions when the surveys are completed.

Brain MusicExperimental

The Brain Music study intervention will consist of a brain mapping data acquisition session to create the personalized music, followed by 5 weekly sessions to adjust the music that participants will listen to at home on a daily basis. Initial data acquisition and weekly sessions will take about 30 minutes. Additional time of 15-20 minutes will be required prior to sessions when the surveys are completed.

Usual CareOther

The Usual Care control group will continue to be followed in the Memory clinic at intervals determined by their clinician. Participants will complete the pretest and post-test assessments and surveys at baseline and at the end of 5 weeks.

Other: Nonlinear dynamical neurofeedback (NLD), Low energy neurofeedback system (LENS), Brain Music, Usual Care

Sites

1 site in 1 country

  • Providence Care HospitalKingston, Ontario, Canada